Introduction
Calixarenes, in general, belong to an interesting class of compounds. [1] [2] [3] They are widelyu sed for the encapsulationo f small molecules, ions, [4] pharmaceuticals, andn atural compounds [5] like amino acids or proteins. [6] The host-guest chemistry of calixarenes [7] is known for the transportation of pharmacological relevant compounds, [8] [9] [10] as reactors for catalysis, [11] [12] [13] or to functionalize nanoparticles. [14, 15] Other applications involvec alixarenes as extractinga gents for (radio)metal ions [16, 17] in the environmenta nd as chemicals ensors [18, 19] for the determination of cations [20] and anions. [21] In this regard, a large variety of special functionalized calixarenes was prepared.
Combining crown ethers and calixarenes is beneficiali nsofar as crown ethers are known to be useful candidates for chelating metal ions. [22] [23] [24] Calixcrowns, in contrastt on ormal calixarene derivatives, lead to higher stability constants and to higher selectivities for metal cations, in most cases. [25] Essentially,inr adiopharmacy,h igh complex stabilities are required to avoid the release of the radiometal from the resulting complex in vivo. [26] This is especially important for the use of group 2 (radio)metal ions like Sr 2 + ,B a 2 + ,o rR a 2 + ,a st here are no suitable ligandsk nowns of ar. [27] Furthermore, at argeting unit has to be introduced to the ligand to address the motif of biological or pharmacological interest.
The aim of this investigation was the determination of stability constants of calix [4] crowns with barium ions through NMR and UV/Vis titration. Thereby,d ependence on their cavity size and furtherf unctionalization was explored. Moreover,t he ligand-ion-interaction was examined by performing pH-dependent two-phase extraction studies with radioactive[
133 Ba]Ba 2 + . Barium is not only am etal of radiopharmaceutical interest, but the non-radioactive isotopes could also serve as surrogates for radium-223/-224. These two radium isotopes have suitable half-lives and nucleard ecay properties that make them useful tools for a-particle therapy.U ntil now,[ 223 Ra]RaCl 2 (Xofigo)i s the only EMA-and FDA-approved radiopharmaceutical for atherapeutic applications. [28] [
223 Ra]RaCl 2 directly addresses the bone.T oa ccess other targets, chelate complex formation is essential. The obtained results of the barium studies give an idea of the complex formation behavioro fr adium, as direct studies with radium are not suitable, owing to the high radioactivity and al ong half-life.
Results and Discussion
Al arge variety of functionalized calix [4] crown ethersa sw ell as some of their complexes with Ba 2 + and Ra 2 + are known from the literature. [27, [29] [30] [31] Only little is known about the respective complex stabilityc onstants. Mainly,e xtraction studies with these calix compounds and (radio)metals were accomplished.
The basic compound 5,11,17,23-tetrakis(tert-butyl)-25,27-dihydroxycalix [4] arene-crown-6 (1)w as selected as the starting As eries of modified calix [4] crown-6 derivatives was synthesized to chelate the heavy group 2m etal barium, which serves as an on-radioactive surrogate forr adium-223/-224;r adionuclides with promising properties for radiopharmaceutical use. These calixcrowns were functionalized with either cyclic amide moieties or with deprotonizable groups, and the corresponding barium complexes were synthesized. Stability constants of these complexes werem easured by using NMR and UV/Vis titration techniques to determine logK values of > 4.1. Further extraction studies were performed to characterize the binding affinity of calixcrownst or adioactiveb arium-133.A dditionally, the ligands containing cyclic amides werei nvestigated regarding their rotational barriers by using temperature-dependent NMR measurements. material. However,i tw as proveni ne xtraction studies that its cavity fits best for heavier group 2m etals. [32] For the recent studies, this scaffold was further functionalized with deprotonizable groups other than hydroxy groups. These groups are also knownt os tably bind (Sr 2 + ), Ba 2 + ,a nd Ra 2 + with good selectivity over Mg 2 + and Ca 2 + . [27] Based on compound 1,f ivec alixarenes with distinctively differing functionalities were chosen to be further investigated (compounds 3, 5-8). Compound 3 is as imple deprotonizable carboxylic acida nd the starting compound forf ollowing modifications. The calix derivatives 7 and 8 are easily deprotonizable, owing to their electron-withdrawingg roups. Furthermore, the amide nitrogena tom plays an important role in the ligand-metal coordination.Compounds 5 and 6 were prepared to increase the steric demandi no rder to avoid the releaseo f Ba 2 + .T he preparation of all functionalized calixarenes started from calix [4] crown-6 derivative 1, [31, 33, 34] which was further converted into diester 2.A fter saponification, the resulting diacid 3 was reactedw ith oxalyl chloride to give dichloride 4.T he chloridew as reactedw ith the respective amines and amides withouti solation and purification to give calixarenes 5-8.I n the case of the piperazine and the hydroxamicd erivatives 6 and 8,af inal deprotection step was necessary.T he preparation of the calix compounds 2-8 is shown in Scheme 1.
During the characterization of the calix compounds, the analysiso ft he 1 HNMR spectra of morpholine compound 5 and piperazine derivative 6 indicated an amide rotational barrier,w hich could cause reduced complex stabilities. For a deeper understanding, compound 11 [35] was synthesized from the starting materials 9 and 10 (Scheme 2), which functions as am ono-structural element of calix derivative 5.T emperaturedependent NMR experiments werep erformed (see Figure 1 and the Supporting Information) in different solvents (CDCl 3 , [D 3 ]acetonitrile and/or [ D 6 ]DMSO). The coalescence temperature T C andt he difference in chemical shifts expressed as Dn were determined to calculate the rotation barrier DG # of compounds 5, 6,a nd 11,a ccording to the Arrheniuse quation. [36] These results are summarized in Ta ble 1.
In general, the rotationb arriers for calix derivatives 5 and 6 are higher (DG # ! 66 kJ mol
À1
)t han for the mono-compound 11 (DG # = 62.4-65.6 kJ mol
), independento ft he solvent used. This is explainable by the steric demand of the crown ether bridgeo ft he calix or by the calix scaffold itself. Furthermore, two independentb arriers were found:o ne for the amide site and one for the amine or ether site. This behavior was shown for similarc ompounds. [36] However,t his resultsf rom the different conformationso ft he 6-membered ring system.A dditionally,asingle-crystal X-ray structurea nalysis was performed on 11.T he compound crystallized in the orthorhombic space Scheme1.Synthetic scheme for preparing the calix [4] crowns 2-8. Reagents and conditions: a) NaH, ethyl bromoacetate, NaI, 50 8C, overnight; b) Me 4 NOH, methanol, 55 8C, overnight;c)oxalylc hloride, CCl 4 ,658C, 5h; d) morpholine, Et 3 N, dichloromethane,r oomtemperature, overnight;e)Nboc-piperazine, Et 3 N, dichloromethane,r oom temperature, overnight;f)trifluoroacetic acid, dichloromethane, room temperature, 2h;g)trifluoromethanesulfonamide, NaH, THF,room temperature, overnight;h)O-benzylhydroxylamine·HCl,pyridine, THF,358C, overnight;i )Pd/C-H 2 ,aceticacid/methanol (v/v = 1/3), room temperature, overnight.
Scheme2
.Synthetic scheme to prepare 1-morpholino-2-phenoxyethan-1-one (11) . Reagents and conditions: a) NaH, THF,458C, overnight. .N itrogen atom N1 points out of the mean plane of the surrounding atoms by only 0.122 .I ti ss upposed to be ap lanar arrangement.F urthermore, the average value of the bond angles around nitrogen atom N1 is calculated to be 119.38, leadingt ot he result that the C1ÀN1 contact has, at least to some extent, p-bonding character.T his partial double-bond characterl imits the ability of the molecule to rotate about this bond. In fact, two isomerse xist in the solidi na1:1r atio. As uperimposition of the two isomers is presented in Figure 3 . This was obtained by fitting the morpholine and the phenyl residue of both isomerso nt op of each other.I ti sn icely seen from Figure 3t hat the two atropisomers differ in the orientation of the carboxylic and with respectt ot he two attached ring systems. This structural feature is in good accordance with the observedN MR properties.
Preparation of the respectiveb arium complexes
was executed by adding 1equivalent of the respective calixarene to 5equivalents of Ba(ClO 4 ) 2 ,b oth dissolved in acetonitrile. The resulting solution was then treated by ultrasound for 1min at ambient temperature. After removal of the solvent, the residue was treated with chloroform and filtered. Ba(ClO 4 ) 2 is not soluble in chloroform and, thus, the filtrate containedt he pure barium complex. Attempts to purify the complexes using columnc hromatography with silica gel were unsuccessful. After this procedure, only the respective ligand was obtained.T oe vidence the formation of the complexes,NMR spectra were recorded in CDCl 3 .The synthesis procedure of the barium complexes is shown in Scheme 3. Ac omparisono ft he spectra of ligand 7 and its complex [Ba-7] is showni nF igure 4. Selected chemicalshifts are listed in Table 2 .
In the past, we described ac onvenientw ay to determine complex stability constantsf or calix 1 using 1 HNMR measurements. [31] However,d etermination of the stability constants for the other ligands 5-8 wasn ot amenable, owing to the hostguest complexation equilibrium. The equilibrium showeda slow exchange rate compared to the NMR timescale. [37] This leads to two speciesi nt he 1 HNMR spectrum. Instead, UV/Vis measurementsw ere used. For this purpose, the calix ligand was dissolved in acetonitrile and aliquots of Ba(ClO 4 ) 2 in acetonitrile were added, which causedaclear change in the absorption. This is shown in Figure 5 , based on the example of compound 7 and its complex .C onsidering one wavelength with ah igh change in absorption, the stoichiometry of the complexw as determined from the diagram titration curve ( Figure 6 ).
All titration experiments showedt he presenceo fac omplex with a1:1 stoichiometry,f ormed by ligands 5-8 with Ba(ClO 4 ) 2 . The resultsa re summarized in Table 3 ( all titration experiments can be found in the SupportingI nformation).
The introduction of groups with steric demands eems to have no high influence on the complex stability constant -8] .B oth groups also have quite low pK a values. [38, 39] This leads to the conclusion that these functions serve as anions for Ba 2 + and, thus, stabilize the whole complex due to the formation of ar eal ion pair.
For future radiolabeling purposes,e xtraction studies were first performed by using the radionuclide barium-133 (half-life: 10.5 a) as [
133 Ba]BaCl 2 and functionalized calixarene ligands 5-8 as af unctiono fp H( 2, 6, and 10). For this experiment, equimolar amountso fc arriera dded [
133 Ba]Ba 2 + and the respective ligand 5-8 were used. The results in Ta ble 4a re expressed as relative portions (average values) of the total startinga ctivity in the aqueous phase, which were extracted to the ligand containing chloroform as the organic phase.
Highest extractionv alues were found for ligand 7.O wing to its high electron-withdrawing property,t he trifluoromethanesulfonyl residue has ah igh influence on the deprotonation of the amide. Compared to compounds 5, 6,a nd 8,t here was a high extraction rate even at lower pH values.Aslight enhancement of the extraction for compounds 5, 6,a nd 8 was detected at pH 10, which is relatedt ot he entire deprotonation of the ligands.
Conclusions
As election of six calixcrown-based ligands 1, 3, 5-8 was synthesized, including two new compounds, 5 and 6,t oi nvestigate their complexation properties with barium. During the product characterization by using NMR, ar otation barrierw as determined for the morpholine ligand 5 and piperazine derivative 6.T emperature-dependent NMR measurements were per- As ar esult,t he influence of the bulky piperazine and morpholine residues had no benefit on the complexs tabilityc ompared to the basic compound 1. Only compound 7 showed ah ighe xtraction rate over a wide pH range in extraction studies with [
133 Ba]BaCl 2 .Arelative extraction of 90 %o ft he starting radioactivity was determined for physiological conditions (pH 6) and even an extraction of 50 %u nder acidic conditions (pH 2). This experiment proved that the two deprotonizable groups of 7 enhancedthe stability of the complex significantly.I np articular,t he trifluoromethylsulfonyl amide moiety, which is expected to be the most acidic group of our investigation and easyt od eprotonate, seemed to form strong ionic interactions.
For the general aim of ar adiopharmaceutical usage of barium and radium, furtherm odifications are required. Therefore, it will be necessary to focus on highly acidic functionalities like the trifluoromethylsulfonyl amide group and on ar igid backbone like the calixcrown skeleton. Finally,f urther functional groups have to be introducedt oe nable water solubility and biocompatibility.
Experimental Section General
All chemicals were purchased from commercial suppliers and used without further purification, unless otherwise specified. Anhydrous tetrahydrofuran (THF) was purchased from Acros, anhydrous Ba(ClO 4 ) 2 was purchased from Alfa Aesar,a nd deuterated solvents were purchased from deutero GmbH. Compounds 1-3, 7, [33] and 8 [40] were prepared according to the literature. [ 133 Ba]BaCl 2 was purchased from Polatom. NMR spectra of all compounds were recorded on an Agilent DD2-400 MHz NMR or an Agilent DD2-600 MHz NMR spectrometer with ProbeOne probe. Chemical shifts of the 1 H, 19 F, and 13 Cs pectra were reported in parts per million (ppm), using tetramethylsilane (TMS) as an internal standard for 1 H/ 13 Ca nd CFCl 3 for 19 Fs pectra. Mass spectrometric (MS) data were obtained on aX evo TQ-S mass spectrometer (Waters) by using electrospray ionization (ESI). The melting points were determined on aG alen III melting point apparatus (Cambridge Instruments &L eica) and are uncorrected. Thin layer chromatography (TLC) detections were performed by using Merck Silica Gel 60 F 254 sheets. TLC plates were developed by visualization under UV light (l = 254 nm). Chromatographic separations were accomplished by using an automated Biotage Isolera Four silica gel column chromatography system and appropriate Biotage KP-SIL SNAP columns. UV/Vis measurements were realized at aS pecord 50 by Analytik Jena instrument. Radioactive count rates were detected by the gamma spectrometer ISOMED 2160. Diffraction data were collected with aB ruker Nonius Apex Kappa-II CCD diffractometer, using graphite-monochromated Mo K a radiation (l = 0.71073 )a nd the measurement was performed at À150 8C. The structure was solved by direct methods and refined against F 2 by full-matrix least-squares using the program suites from G. M. Sheldrick. [41, 42] All non-hydrogen atoms were refined anisotropically;a ll hydrogen atoms were placed on geometrically calculated positions and refined by using riding models. CCDC 1817790 contains the supplementary crystallographic data for compound 11.
[43] The calculation of the stability constants was accomplished using the HypSpec 1.1.18 program. Calix 3 (120 mg, 0.12 mmol) was suspended in CCl 4 (5 mL), oxalyl chloride (900 mg, 7.1 mmol) was added and the mixture was stirred for 5hat 65 8C. After cooling to room temperature, the solvent was removed, anhydrous dichloromethane (5 mL) was added, and am ixture of morpholine (27 mg, 0.31 mmol) and triethylamine (31 mg, 0.31 mmol) dissolved in 5mLo fd ichloromethane was also added. After stirring at room temperature overnight, the mixture was filtered. The filtrate was washed with aqueous HCl (10 %, 15 mL), saturated hydrogencarbonate solution (15 mL), and water (3 15 mL). The organic layer was dried, the solvent was removed, and the crude product was purified by using automated column chromatography (solvent:d ichloromethane ! dichloromethane/ methanol 5:1) to give 5 ac olorless solid (85 mg, 62 %). M.p. 105 8C; Calix 3 (430 mg, 0.445 mmol) was dissolved in CCl 4 (30 mL), oxalyl chloride (3.2 g, 25.3 mmol) was added and the mixture was stirred for 5h at 65 8C. After removal of the solvent, the crude product was dissolved in anhydrous dichloromethane (15 mL) and N-Boc-piperazine (207 mg, 1.11mmol) and triethylamine (112 mg, 1.11mmol) were added. After stirring at room temperature overnight, the mixture was filtered, the filtrate was washed with aqueous HCl (10 %, 20 mL), and saturated hydrogencarbonate solution (20 mL) and water (3 20 mL). The organic layer was dried, the solvent was removed, and the crude product was purified by using automated column chromatography (solvent:d ichloromethane ! dichloromethane/methanol 7:1) to give Boc-6 as ac olorless solid (310 mg, 53 % 1-Morpholino-2-phenoxyethan-1-one (11) Phenol 10 (298 mg, 3.17 mmol) was dissolved in anhydrous THF (15 mL) and NaH (138 mg, 3.45 mmol, 60 %i nm ineral oil) was added. Afterwards, 2-chloro-1-morpholinoethan-1-one 9 (250 mg, 1.67 mmol) dissolved in chloroform (5 mL) was added dropwise and the resulting mixture was allowed to stir at 45 8Co vernight. The solvent was removed;t he crude was dissolved in dichloromethane (20 mL) and washed with water (2 20 mL). The organic layer was dried over Na 2 SO 4 ,t he solvent was removed, and the crude product was purified by using automated column chromatography (solvent:p etroleum ether/ethyl acetate 4:1 
Synthesis of the Ligands

Synthesis of the Barium Complexes
The respective ligand 5-8 (1 equiv) and Ba(ClO 4 ) 2 (5 equiv) were dissolved in acetonitrile. The mixture was treated with ultrasound for 1min, the solvent was removed, and chloroform was added. Afterwards, the solution was filtered and the filtrate contained the barium complexes in quantitative yield.
[ 
UV/Vis Titration Measurements
As olution of the corresponding ligand was prepared in acetonitrile. The concentration range was chosen to be 1.0 to 2.5 mm, depending on the absorption maxima of the compound. This solution (2.5 mL) was pipetted into aq uartz cuvette of 1cmo ptical path length. The titration was performed by as tepwise addition of a2 5mm Ba(ClO 4 ) 2 solution in acetonitrile. The absorption spectra were measured in the range of 190 to 400 nm. 
